Brookfield Infrastructure (NYSE:BIPC) shares have bounced back by nearly 2% after a mixed trading week. Investors seem keen to revisit the company's fundamentals, focusing on recent performance trends and valuation in today's uncertain utility market.
See our latest analysis for Brookfield Infrastructure.
Brookfield Infrastructure’s share price return over the past year reflects a steady climb, while its three-year total shareholder return of 26% suggests durable, long-term growth. Recent...
If you are looking at WD-40 stock and wondering whether now could be the right time to buy, sell, or simply hold tight, you are not alone. Lately, WD-40 has been on a bit of a rollercoaster. The price at last close was $194.2, and over the last week, the stock slipped by 2.4%. Zooming out to the past month, we see a 9.3% drop, and if you have been watching all year, you have likely noticed the stock is down 19.1% year to date. In fact, over the past year, it has declined 23.2%. These numbers...
If you have been watching ThredUp lately, you know it is one of those rare stocks that keeps drawing your attention. Whether you are holding after that massive 1-year surge or you are still weighing your next move, there is a lot to unpack. ThredUp has soared an eye-catching 1111.0% over the last year, with a staggering 568.8% gain year-to-date. Even after a recent 30-day dip of -10.7%, it has still notched a respectable 2.4% gain in the past week. This reminds investors that volatility can...
If you’re considering what to do with Virtu Financial right now, you’re not alone. The stock has certainly made waves, and even if recent weeks have been rocky, the long-term story is grabbing attention. Shares closed at $33.64, and while the last week saw a dip of 4.5% and the past month is down 18.9%, these shorter-term moves come after years of hard-earned gains. Take a step back, and you’ll see Virtu has delivered a solid 8.6% return over the past year, an impressive 74.4% over three...
Ovid Therapeutics recently announced positive topline results from its Phase 1 study of OV329, a next-generation GABA-aminotransferase inhibitor targeting drug-resistant epilepsies, demonstrating significant GABAergic inhibition and strong safety outcomes in 68 healthy volunteers.
This clinical milestone signals potential advancement in the treatment of drug-resistant epilepsies and attracted new institutional investors through a substantial private placement.
We'll explore how OV329’s early...
If you’re sitting on the fence about Albertsons Companies, you’re not alone. The grocery giant’s stock closed at $17.38 recently, and investors are wondering if now is the moment to buy, hold, or wait for a better price. Recent price action has been anything but dull: in the last week alone, Albertsons stock dipped by 1.0%, deepening a 10.0% slide over the past month. The stock is down 11.6% so far this year, which might feel discouraging, but if you take a step back, the 81.8% gain over the...
Thinking about what to do with Globe Life stock? You are definitely not alone. Friends and clients keep asking whether it is the right time to get in, stay patient, or take some profits. Globe Life’s price has had its share of twists lately, most notably a dip of 4.8% in the last week and 2.1% across the past month. Yet, look a little further back and things get more interesting. The stock’s up a strong 22.6% so far this year and an impressive 30.2% over the last twelve months. That kind of...
On September 24, 2025, Zura Bio Limited adopted an Executive Severance Benefit Plan, outlining compensation for executives if terminated without cause or upon resignation for good reason, especially in the context of a change in control.
This move comes as the company, which reported having US$154 million in cash with a reported runway of 3.5 years as of June 2025, faces scrutiny over its increasing cash burn and potential funding needs.
We'll examine how concerns around Zura Bio's executive...
If you’re standing at a crossroads deciding what to do with Hanover Insurance Group stock, you’re not alone. The stock has been showing some serious momentum this year, drawing investors’ attention with a steady climb and sparking plenty of conversation around growth prospects. In the past five years, the stock has more than doubled, returning 115.5%, while 2024 alone has already brought an impressive 20.5% gain. Even in the last month, Hanover added 3.6%, suggesting that recent shifts in the...
So you are looking at GATX stock and wondering if now is the right moment to make a move. If you have been watching GATX lately, you have seen the share price post an impressive journey, climbing nearly 185% over the past five years. Just in the past year, the stock is up 37.7%, and year-to-date it has gained another 15.7%. Even over the past month, GATX has delivered a healthy 5.1% return, and while the past week showed a slight dip of -0.6%, the big picture is hard to ignore. Some of these...
If you’ve been scanning the markets wondering whether now is the right time to buy, hold, or move on from Alexander & Baldwin, you’re not alone. This stock can puzzle even seasoned investors, especially after a rollercoaster of performance. Over the past five years, Alexander & Baldwin’s price has soared nearly 80%, which is impressive for a real estate-focused name. Those who’ve sat tight since 2021 are still up over 22% despite the flat year-over-year returns, and a slight dip of -0.4% in...
If you’re staring down McGraw Hill’s stock chart this week and feeling a little uncertain, you’re not alone. The stock closed at $11.99 most recently, which might look tempting for bargain hunters, but not without a second glance. Over the past month, shares have slipped by 19.6%, and they are down 12.8% in just the last 7 days. Year to date, there has been a drop of 29.5%. That is some heavy turbulence for any portfolio, and it has plenty of investors asking whether this is a blip or a...
Thinking about what to do with Zurn Elkay Water Solutions stock? You are not alone. Investors have watched this water solutions company steadily climb, with shares up 4.9% in the last 30 days and a whopping 29.9% over the past year. The longer-term numbers are even more eye-catching, showing a return of 96.6% over three years and a stunning 217.9% run across five years. After a quieter week, with the stock up just 0.1%, some might wonder if the stock is catching its breath for another sprint...
Trying to figure out what to do next with Sila Realty Trust stock? You are not alone. Investors are weighing their choices as Sila’s price has seen a few twists over the past year. The stock recently closed at $24.38. Over the last seven days, it slipped by 2.9%, and the last month shows a similarly cautious dip of 2.2%. Yet, zooming out a bit, Sila is up 1.6% so far this year and 2.7% over the last twelve months. While these are not wild swings, the steady, if modest, climb has caught the...
If you own UDR stock or have it on your watchlist, you are probably weighing your next move right now. After all, UDR's recent share performance has inspired plenty of second-guessing. The stock is down 2.2% over the past week, down 5.2% in the last month, and has drifted lower by 14.5% year-to-date. After a difficult year, UDR’s price is now about 15% below where it stood a year ago, despite a longer-term gain of 22.6% over five years. It is clear that while multifamily REITs like UDR have...
If you are wrestling with the question of what to do next with Autoliv stock, you are not alone. The past couple years have been a remarkable journey for the company and its shareholders, and momentum shows no signs of cooling. Just think, Autoliv's share price has surged by an impressive 38.7% since the start of this year, and it's up 40.5% from a year ago. Stretch that window to the past three years, and you are looking at an eye-popping 90.5% return. Even over the last month and week...
Thinking about what to do with Bright Horizons Family Solutions stock? You're not alone. Whether you already have shares or you’re just getting curious about this company, it’s one of those stocks that invites a lot of questions about whether it’s undervalued, expensive, or maybe somewhere in between. Over the past year, the stock has dropped nearly 22%, which feels like a steep slide. But if we zoom out, you’ll notice it’s actually up more than 88% over the last three years, even after a...
If you are wondering what to do next with Guardian Pharmacy Services stock, you are in good company. With its shares closing at $23.94 and a one-year return of 37.9%, the company has caught plenty of attention from investors seeking growth. The start of the year brought optimism, with the stock up 20.4% year-to-date, but the past month has tested that resolve, as the price dropped 15.7% in the last 30 days and 8.0% over the past week. This recent dip may stir anxiety or curiosity, depending...
If you’ve been watching Steelcase stock lately, you’re not alone. Whether you’re wondering if now is the time to buy, hold, or cash in some gains, there’s plenty to consider. After notching a 0.7% gain in just the last week, and more than doubling investors’ money over the past three years with a 171.5% return, Steelcase has certainly caught the market’s attention. That momentum is not just a blip; with a 47.6% gain year-to-date, the company’s upward move reflects both a renewed sense of...
Petco Health and Wellness Company (WOOF) stock has caught the attention of investors as it navigates recent market movements. The company's share price has changed over the past month, offering fresh insight into how the market views its outlook.
See our latest analysis for Petco Health and Wellness Company.
Momentum for Petco Health and Wellness Company has faded, with the share price edging only slightly higher in recent months and the 1-year total shareholder return down nearly 29%. Recent...